HSA Approval

MYOLID CAPSULES 15 MG

Approval Number

SIN16953P

Drug Name

Product Name

MYOLID CAPSULES 15 MG

Approval Date

February 19, 2024

Registrant

DKSH SINGAPORE PTE. LTD.

Regulatory Information

Registrant

DKSH SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

CAPSULE

Route of Administration

ORAL

Medical Information

ATC Code

L04AX04

ATC Item Name

lenalidomide

Manufacturer Information

Pharmaceutical Manufacturer

DKSH SINGAPORE PTE. LTD.

Manufacturers

BIOCON PHARMA LIMITED

Active Ingredients

Ingredient Name

Lenalidomide

Strength

15mg

Drug MonographProparacaine

Documents

Package Inserts

Myolid Capsule PI.pdf

Approved: February 19, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

MYOLID CAPSULES 15 MG - HSA Approval | MedPath

AI-Powered Research

Premium Access

MYOLID CAPSULES 15 MG

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

Documents

Package Inserts

MedPath

Product

Company

Legal